Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Satoshi-Era Bitcoin Whale Moves $1.2 Million Worth Of BTC After 13 Years
-
Key Metric Suggests Institutional Traders Have Completed Their BTC Accumulation — Bullish Move Incoming?
-
Tether Ups Bitcoin Bet With BTC Mining In Uruguay
-
Why Max Keiser Is Highly Optimistic About Bitcoin Cracking $220,000 In ‘A Flash’
-
Analyst Predicts 90% Likelihood of SEC Approving Bitcoin Spot ETF by January 2024 or Earlier
